Domestic pharmaceutical firms' R&D overseas projects seen intensifying

Published: 2004-08-23 07:00:00

Updated: 2004-08-23 07:00:00

A number of domestic leading pharmaceutical firms are expected to increase their R&D investment in foreign countries, as the Korea Pharmaceutical Manufacturers Association and the Korea Health Industry Development Institute are pushing ahead with two possible research projects with Scotland and s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK